Free Trial

This company has been marked as potentially delisted and may not be actively trading.

resTORbio (TORC) Competitors

resTORbio logo

TORC vs. WHWK, VIRI, PYRGF, VHAQ, AADI, OSTX, NBRV, ATNM, EGRX, and ELYM

Should you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include Whitehawk Therapeutics (WHWK), Virios Therapeutics (VIRI), PyroGenesis Canada (PYRGF), Viveon Health Acquisition (VHAQ), Aadi Bioscience (AADI), OS Therapies (OSTX), Nabriva Therapeutics (NBRV), Actinium Pharmaceuticals (ATNM), Eagle Pharmaceuticals (EGRX), and Eliem Therapeutics (ELYM).

resTORbio vs. Its Competitors

resTORbio (NASDAQ:TORC) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical preparations industry companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations.

In the previous week, resTORbio's average media sentiment score of 0.00 equaled Whitehawk Therapeutics'average media sentiment score.

Company Overall Sentiment
resTORbio Neutral
Whitehawk Therapeutics Neutral

Whitehawk Therapeutics has higher revenue and earnings than resTORbio. resTORbio is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
resTORbioN/AN/A-$82.74M-$2.41-0.28
Whitehawk Therapeutics$25.98M3.66-$63.69M$0.1612.63

resTORbio has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

46.2% of resTORbio shares are held by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 11.8% of resTORbio shares are held by company insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Whitehawk Therapeutics has a net margin of 99.42% compared to resTORbio's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat resTORbio's return on equity.

Company Net Margins Return on Equity Return on Assets
resTORbioN/A -78.12% -71.63%
Whitehawk Therapeutics 99.42%-56.73%-48.68%

Summary

Whitehawk Therapeutics beats resTORbio on 9 of the 10 factors compared between the two stocks.

Get resTORbio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TORC vs. The Competition

MetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$24.89M$790.52M$5.54B$8.99B
Dividend YieldN/A4.84%5.25%4.04%
P/E Ratio-0.381.3027.5520.17
Price / SalesN/A225.41432.66125.29
Price / CashN/A23.4436.8257.86
Price / Book0.306.138.105.60
Net Income-$82.74M-$27.58M$3.17B$248.58M

resTORbio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TORC
resTORbio
N/A$0.68
+5.2%
N/A-39.3%$24.89MN/A-0.38N/A
WHWK
Whitehawk Therapeutics
N/A$1.99
+0.5%
N/AN/A$93.28M$25.98M0.0040
VIRI
Virios Therapeutics
N/A$4.80
-0.6%
$5.00
+4.2%
+1,782.4%$92.44MN/A-17.785Gap Up
PYRGF
PyroGenesis Canada
0.1033 of 5 stars
$0.35
-2.5%
N/A-43.0%$64.48M$9.14M-5.7690News Coverage
Gap Down
VHAQ
Viveon Health Acquisition
N/A$11.00
flat
N/A+10.0%$62.26MN/A0.002High Trading Volume
AADI
Aadi Bioscience
0.645 of 5 stars
$1.98
-0.5%
$1.67
-15.8%
+44.5%$48.90M$25.07M-0.8740
OSTX
OS Therapies
2.7842 of 5 stars
$1.62
-6.4%
$18.00
+1,011.1%
N/A$45.52MN/A-1.88N/A
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
ATNM
Actinium Pharmaceuticals
2.9553 of 5 stars
$1.43
+0.7%
$4.00
+179.7%
N/A$44.61MN/A-1.0330Positive News
EGRX
Eagle Pharmaceuticals
N/A$3.25
+8.3%
N/A-45.9%$42.21M$257.55M0.00100
ELYM
Eliem Therapeutics
N/A$1.28
+1.6%
N/A-81.1%$38.08MN/A-2.429

Related Companies and Tools


This page (NASDAQ:TORC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners